A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 179
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : BSO
Long Form : bilateral salpingo-oophorectomy
No. Year Title Co-occurring Abbreviation
2019 Association of Bilateral Salpingo-Oophorectomy Before Menopause Onset With Medial Temporal Lobe Neurodegeneration. IQR, MCSA, MOA-2, MRI, PiB-PET
2019 Effects of bilateral salpingo-oophorectomy on menopausal symptoms and sexual functioning among women with a BRCA1 or BRCA2 mutation. QOL
2019 Phase II Trial of Chemopreventive Effects of Levonorgestrel on Ovarian and Fallopian Tube Epithelium in Women at High Risk For Ovarian Cancer: An Nrg Oncology Group/Gog Study. FTE
2019 Primary Peritoneal Cancer Two Decades after a Bilateral Salpingo-Oophorectomy. EOC
2019 Transvaginal Natural Orifice Transluminal Endoscopic Surgery for Female-to-Male Transgender Men. NOTES, VH
2018 A Case of Carcinoid Syndrome Due to Malignant Metastatic Carcinoid Tumor with Carcinoid Heart Disease Involving Four Cardiac Valves. 5-HIAA, CT, PFO, TAH
2018 A successful live birth with in vitro fertilization and thawed embryo transfer after conservative treatment of recurrent endometrial cancer. ---
2018 Combined Oocyte Retrieval and Robot-assisted Hysterectomy in a Super Morbidly Obese Patient with Endometrial Carcinoma. RA-TLH
2018 Concurrent risk-reduction surgery in patients with increased lifetime risk for breast and ovarian cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database. NSQIP, RRM
10  2018 Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation. BM, LYG, QALYs, SHI
11  2018 Eating disorders in premenstrual dysphoric disorder: a neuroendocrinological pathway to the pathogenesis and treatment of binge eating. GnRH, PMDD
12  2018 Hidden estrogen production from ovarian remnants leading to progression of disease in metastatic breast cancer. ORS
13  2018 Intra-operative evaluation of prophylactic hysterectomy and salpingo-oophorectomy specimens in hereditary gynaecological cancer syndromes. IOE, LS, TH
14  2018 Is Hormone Replacement Therapy Safe in Women With a BRCA Mutation?: A Systematic Review of the Contemporary Literature. HT
15  2018 The feasibility and safety of transvaginal bilateral salpingo-oophorectomy. ---
16  2018 To oophorectomy or not to oophorectomy: Practice patterns among urologists treating bladder cancer. RC, SUO
17  2017 An unexpected diagnosis of primary omental endometrial stromal sarcoma in a patient with acute right abdominal pain: A case report and review of literature. EESS, HRT
18  2017 Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience. BRCA
19  2017 Bilateral Salpingo-oophorectomy Compared to Gonadotropin-Releasing Hormone Agonists in Premenopausal Hormone Receptor-Positive Metastatic Breast Cancer Patients Treated with Aromatase Inhibitors. AI, CI, GnRHa, PFS
20  2017 Bilateral Salpingo-Oophorectomy Versus GnRH Analogue in the Adjuvant Treatment of Premenopausal Breast Cancer Patients: Cost-Effectiveness Evaluation of Breast Cancer Outcome, Ovarian Cancer Prevention and Treatment. CI, GnRH, QALYs
21  2017 Cholecystectomy and Hysterectomy: A Least Invasive Approach. ---
22  2017 Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma? CSS, FSS, OCCC, OP, OS, SEER
23  2017 Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study. CI, HR
24  2017 Improving the clinical management of women with borderline tumours: a recurrence risk scoring system from a French multicentre study. BOTs, FIGO, RSS
25  2017 Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata. ---
26  2017 Narrated video of a re-do colposuspension. MUCP, TAH
27  2017 Ovarian preservation improves overall survival in young patients with early-stage endometrial cancer. CI, EC, HR, OP, OS, RFS, RR
28  2017 Risk of Diabetes After Hysterectomy With or Without Oophorectomy in Postmenopausal Women. WHI
29  2017 Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients. AC
30  2017 Survival Impact of Ovarian Preservation on Women With Early-Stage Endometrial Cancer: A Systematic Review and Meta-analysis. CI, HR
31  2017 The Appraisement of Antioxidant and Oxidant Status in Women Undergoing Surgical Menopause. TH
32  2017 Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy. HRT, RRSO
33  2016 A Dedicated Follow-Up Clinic for BRCA Mutation Carriers. ---
34  2016 Clinical and Pathological Characteristics of Incidental Diagnostic Early Occult Malignancy After Risk-Reducing Salpingo-Oophorectomy in BRCA Mutation Carriers. ---
35  2016 Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy. HGSC, STIC
36  2016 Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort. CI, OR
37  2016 Hysterectomy, Oophorectomy, and Risk of Thyroid Cancer. ---
38  2016 Long-term cancer risk after hysterectomy on benign indications: Population-based cohort study. ---
39  2016 Management Strategies for the Ovaries at the Time of Hysterectomy for Benign Disease. ---
40  2016 Potential adverse effects of prophylactic bilateral salpingo-oophorectomy on skin aging in premenopausal women undergoing hysterectomy for benign conditions. ---
41  2016 Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study. AOR, HT, VT
42  2016 Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review. CI, HR
43  2016 Serous tubal intraepithelial carcinoma arising from the intrauterine portion of the fallopian tube after bilateral salpingo-oophorectomy. RRSO, STIC
44  2016 Small cell carcinoma of the ovary-hypercalcemic type (SCCOHT): A review of 47 cases. MRT, SCCOHT, USO
45  2016 The role of adjuvant therapy in uterine leiomyosarcoma. ULMS
46  2015 Androgens, Bilateral Oophorectomy, and Cardiovascular Disease Mortality in Postmenopausal Women With and Without Diabetes: The Study of Osteoporotic Fractures. CVD, HRs, SOF
47  2015 Bilateral salpingo-oophorectomy and adhesiolysis with single port access laparoscopy and use of diode laser in a BRCA carrier. SPAL
48  2015 Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial. HT
49  2015 National trends of adnexal surgeries at the time of hysterectomy for benign indication, United States, 1998-2011. BS
50  2015 Outcomes and Cost Analysis in High-Risk Patients Undergoing Simultaneous Free Flap Breast Reconstruction and Gynecologic Procedures. FFR
51  2015 Ovarian cancer risk after salpingectomy: a nationwide population-based study. ---
52  2015 Polymorphisms of estrogen metabolism-related genes ESR1, UGT2B17, and UGT1A1 are not associated with osteoporosis in surgically menopausal Japanese women. ESR1, UGT
53  2015 Risk-reducing surgery in hereditary gynecological cancer: Clinical applications in Lynch syndrome and hereditary breast and ovarian cancer. BRCA, HBOC, RRS, US
54  2015 Salpingectomy as a means to reduce ovarian cancer risk. BSOR, HGSC
55  2015 Single-port versus conventional multiport access prophylactic laparoscopic bilateral salpingo-oophorectomy in high-risk patients for ovarian cancer: a comparison of surgical outcomes. ---
56  2015 The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome. LS
57  2015 [Clinical study of 16 cases of villoglandular adenocarcinoma of uterine cervix]. FIGO, VA
58  2014 Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers. FORCE, PSDO
59  2014 Changing Bodies: Experiences of Women Who Have Undergone a Surgically Induced Menopause. IPA
60  2014 Impact of ovarian preservation in women with endometrial cancer. CI, HR
61  2014 Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review). ORS
62  2014 Obstructive small bowel metastasis from uterine leiomyosarcoma: a case report. TAH
63  2014 Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort. CI, RR
64  2014 Orbital metastasis of endocervical stromal sarcoma: a rare tumor and an uncommon metastasis. ECSS, TAH
65  2014 Persistent bleeding after laparoscopic supracervical hysterectomy. BMI
66  2014 Prognostic factors and outcomes in endometrial stromal sarcoma with the 2009 FIGO staging system: a multicenter review of 114 cases. ER/PR, ESS, OS, RFS
67  2014 The impact of bilateral salpingo-oophorectomy on breast MRI background parenchymal enhancement and fibroglandular tissue. BPE, FGT, FGT
68  2014 The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study. BRCA, CI, HR
69  2014 Total laparoscopic modified radical hysterectomy with lymphadenectomy for endometrial cancer compared with laparotomy. TLMRH
70  2013 A critical evaluation of the evidence for ovarian conservation versus removal at the time of hysterectomy for benign disease. CHD
71  2013 A study to evaluate the cause of bone demineralization in gynecological cancer survivors. BMDs, DEXA, HRT
72  2013 Catalysts to withdrawal from familial ovarian cancer screening for surgery and reactions to discontinued screening: a qualitative study. OCS
73  2013 Circulating levels of monocyte chemoattractant protein-1 and interleukin-7 in women who have undergone bilateral salpingo-oophorectomy. IL, MCP-1
74  2013 Comprehensive management of diffuse leiomyomatosis in a patient with Alport syndrome. ASDL, AUB, ER, TAH
75  2013 Dual-console robotic surgery: a new teaching paradigm. PPALND, TRH
76  2013 Incidence of port site hernias and/or dehiscence in robotic-assisted procedures in gynecologic oncology patients. LND, RA, TLH
77  2013 Increased proliferative background in healthy women with BRCA1/2 haploinsufficiency is associated with high risk for breast cancer. EGFR, sEGFR, TK1
78  2013 Management of genetic syndromes predisposing to gynecologic cancers. ---
79  2013 Successful incorporation of robotic surgery into gynecologic oncology fellowship training. PALND, SH, VCC
80  2013 Uterine sarcomas: review of 26 years at The Instituto Nacional de Cancerologia of Mexico. CS, CT, INCan, LMS, TAH
81  2012 Determinants of the decision to perform prophylactic oophorectomy in association with a hysterectomy for a benign condition. ---
82  2012 Leiomyosarcoma after hysteroscopic myomectomy: a case report. CGA, HPF, LMS
83  2012 Peri-operative outcomes of patients with stage IV endometriosis undergoing robotic-assisted laparoscopic surgery. RALH, USO
84  2012 Risk factors related to febrile morbidity after abdominal hysterectomy. FM, TAH
85  2012 Risk-reducing bilateral salpingo-oophorectomy and sexual health: a qualitative study. RRBSO
86  2012 Same-day discharge in clinical stage I endometrial cancer patients treated with total laparoscopic hysterectomy, bilateral salpingo-oophorectomy and bilateral pelvic lymphadenectomy. BPLND, EC, TLH
87  2012 Systematic lymphadenectomy in patients with clinical stage II endometrial carcinoma: a case report and review of the literature. ---
88  2011 Breast cancer after bilateral risk-reducing mastectomy. RRM
89  2011 Cancer antigen 125 level after a bilateral salpingo-oophorectomy: what is the contribution of the ovary to the cancer antigen 125 level? CA
90  2011 Circulating dehydroepiandrosterone sulfate levels in women who underwent bilateral salpingo-oophorectomy during the menopausal transition. DHEAS, MT, SWAN
91  2011 Factors affecting gynaecologists' decision to perform prophylactic oophorectomy concomitantly with hysterectomy: a Belgian survey. ---
92  2011 Factors affecting the feasibility of bilateral salpingo-oophorectomy during vaginal hysterectomy for uterine prolapse. ---
93  2011 Laparoscopic hysterectomy versus total abdominal hysterectomy: a retrospective comparative study. SO, TAH, TLH
94  2011 Non-closure of peritoneum after abdominal hysterectomy for uterine carcinoma does not increase late intestinal radiation morbidity. TAH
95  2011 Oophorectomy vs ovarian conservation with hysterectomy: cardiovascular disease, hip fracture, and cancer in the Women's Health Initiative Observational Study. ---
96  2011 Practice patterns with hormone therapy after surgical menopause. ET, HT
97  2011 Radical fimbriectomy: a reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development. ---
98  2011 Risk factors associated with the occurrence of breast cancer after bilateral salpingo-oophorectomy in high-risk women. BC
99  2011 Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening tests. ---
100  2011 The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice? RANZCOG, SWAHS